Anti-viral drug Remdesivir would
be made available directly to private hospitals to avoid overcrowding in places designated for its prescription based sale by state authorities to the kin of COVID-19 patients, the Tamil Nadu government said here on Sunday.
Effective May 18, a facility would be made available to private hospitals to register their drug requirement in a portal and only their representatives should collect the medicine from sale depots.
While information on the portal would soon be released, the hospitals must furnish information related to intended recipients, the oxygen dependent patients, the government said in an official release.
The state-run Tamil Nadu Medical Services Corporation provided the drug to government hospitals.
For patients in private facilities, it was being made available to the families of COVID-19 patients through government sale centres in Chennai, Coimbatore, Salem, Tiruchirappalli, Madurai and Tirunelveli.
The government said authorities would monitor if Remdesivir was used by private hospitals only for eligible patients and whether it was sold to patients at the same price at which it was bought from its centres.
Legal action would be taken against those who violate norms and if patients were recommended Remdesivir without any necessity, the government said.
Following a meet chaired by Chief Minister M K Stalin to review the current practice of providing the drug to people through direct sale, the government said only in Tamil Nadu Remdesivir was being sold directly to the families of people infected by the virus.
Overcrowding in places where Remdesivir is being sold made following physical distancing impossible and also led to the possibility of virus spread and hence this has to be avoided, the government said.
There were also complaints alleging that some who got the drug from centres sold it in the black market and experts opined that Remdesivir had a limited efficacy only for patients on oxygen support.
Considering such factors, and to see that people do not face hassles, the Chief Minister advised top officials to change the current practice and provide it only to hospitals.
Relatives of patients should not be tasked to buy the medicine directly, he told the officials.
Medical and Family Welfare Minister Ma Subramaniam and top officials including Health Secretary J Radhakrishnan took part in the meet held at the Secretariat.
On Saturday, public health expert Prabhdeep Kaur tweeted (on overcrowding to get the drug), "This is perfect setting for #Covid19 cluster. Will make lockdown ineffective. Remdesivir is not a life saving drug. Yet, if Govt wants to help patients in private hospitals - it should be given directly to the hospitals @CMOTamilnadu @Subramanian_ma.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)